EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1

Ji-Seon Jeong, Yeokyeong Shin, Shinkyo Yoon, Deokhoon Kim, Josephina Sampson, Richard Bayliss, Jene Choi

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Ji-Seon Jeong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Protein-Tyrosine Kinases, Oncogene Proteins, Fusion, Gene Rearrangement. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene ProteinsProtein-Tyrosine KinasesOncogene Proteins, FusionGene RearrangementNeoplasmsHumansMaleFemaleMiddle AgedAgedAdultProtein Kinase InhibitorsChromosome Breakpoints

Stichwörter der Autor:innen

BreakpointFusion partnerNon-small cell lung cancerROS1 fusionROS1-TKI

Substanzen

ROS1 protein, humanProto-Oncogene ProteinsProtein-Tyrosine KinasesOncogene Proteins, FusionProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Departments of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
  • Departments of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address: jenec@amc.seoul.kr.

Förderung

  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea

Zitieren

APA

Jeong, J. S., Shin, Y., Yoon, S., Kim, D., Sampson, J., Bayliss, R., & Choi, J. (2025). Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116091

Vancouver

Jeong JS, Shin Y, Yoon S, Kim D, Sampson J, Bayliss R, et al. Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116091

BibTeX
@article{Jeong2025,
  author = {Jeong, Ji-Seon and Shin, Yeokyeong and Yoon, Shinkyo and Kim, Deokhoon and Sampson, Josephina and Bayliss, Richard and Choi, Jene},
  title = {Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116091}
}
Kostenlos starten →